COVID-19 Inpatient | COVID-19 Outpatient | Women's Health, Phase COVID-II

I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients

Volunteers
Health Professionals

What is the purpose of this trial?

Identify agents that will result in substantial improvements to the clinical condition of participants with COVID-19.

Trial with
QuantumLeap Healthcare Collaborative
Ages
18 years and older
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Jackie Prinz

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Jon Koff, MD
Associate Professor Term; Associate Director, Fellowship Research, Pulmonary, Critical Care & Sleep Medicine; Medical Director, Center for Phage Biology & Therapy, Yale University; Director, Adult Cystic Fibrosis Program

Sub-Investigators

Last Updated
01/30/2024
Study HIC
#2000028816